A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Lee HC, Shah JJ, Feng L, Manasanch EE, Lu R, Morphey A, Crumpton B, Patel KK, Wang ML, Alexanian R, Thomas SK, Weber DM, Orlowski RZ.
Lee HC, et al. Among authors: weber dm.
Blood Cancer J. 2019 Oct 1;9(10):80. doi: 10.1038/s41408-019-0240-6.
Blood Cancer J. 2019.
PMID: 31575851
Free PMC article.
Clinical Trial.
No abstract available.